P. Portegies

P. Portegies, P. Devriese, R. Enting, 1994, European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery.

Neurological Complications of Hiv Infection

P. Portegies, P. Cinque, M. Bojar, 2010 .

Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.

M. Kersten, R. V. van Lier, P. Portegies, 1996, Blood.

Decreased number of oxytocin neurons in the paraventricular nucleus of the human hypothalamus in AIDS.

D. Troost, D. Swaab, P. Portegies, 1993, Brain : a journal of neurology.

ACUTE MENINGOENCEPHALITIS ON DOSE REDUCTION OF ZIDOVUDINE

P. Portegies, J. Gans, G. Tiessens, 1988, The Lancet.

Progressive multifocal leukoencephalopathy presenting as a solitary gray matter lesion

P. Portegies, J. V. D. van der Meer, E. S. Louwerse, 1998, Journal of Neurology.

Update on HIV-related neurological illness.

B. Brew, P. Portegies, 1991, AIDS.

Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine

R. Zwart, P. Portegies, P. Bolhuis, 1992, Muscle & nerve.

Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis

P. Reiss, P. Portegies, H. Verbrugh, 1997, AIDS.

Low levels of specific T cell activation marker CD27 accompanied by elevated levels of markers for non-specific immune activation in the cerebrospinal fluid of patients with AIDS dementia complex

P. Portegies, R. Hintzen, T. Poll, 1993, Journal of Neuroimmunology.

Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection

P. Reiss, B. Schmand, T. Su, 2015, AIDS.

AIDS Dementia Complex Diagnosis and Drug Treatment Options

P. Portegies, N. Rosenberg, 1998 .

Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection.

P. Portegies, J. Verhoef, M. Tardieu, 1999, Journal of immunology.

Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir

P. Portegies, G. Weverling, S. Jurriaans, 2000, AIDS.

Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis

P. Portegies, J. Stam, C. van Boxtel, 1992, AIDS.

Neurological complications of infection with human immunodeficiency virus type 1 A review of literature and 241 cases

P. Portegies, J. Gans, 1989, Clinical Neurology and Neurosurgery.

Guidelines for the diagnosis and management of neurological complications of HIV infection

A. Chaudhuri, P. Martínez-Martín, P. Portegies, 2004, European journal of neurology.

Reversible blindness in AIDS-related cryptococcal meningitis

P. Portegies, J. Claus, 1998, Clinical Neurology and Neurosurgery.

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

I. Keet, P. Portegies, B. H. Benthem, 1998, The Lancet.

Overexpression of nerve growth factor and basic fibroblast growth factor in AIDS dementia complex

G. Jansen, P. Portegies, J. Verhoef, 1999, Journal of Neuroimmunology.

Chapter 4 " Durable HIV-1-suppression with indinavir after failing lamivudine containing double nucleoside therapy : a randomized controlled trial "

P. Reiss, P. Portegies, N. Foudraine, 2012 .

Durable HIV-1 Suppression with Indinavir after Failing Lamivudine-Containing Double Nucleoside Therapy: A Randomized Controlled Trial

P. Portegies, N. Foudraine, G. Weverling, 2001, Antiviral therapy.

Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine

P. Portegies, F. de Wolf, S. Danner, 2000, AIDS.

Increasing Cerebrospinal Fluid Chemokine Concentrations Despite Undetectable Cerebrospinal Fluid HIV RNA in HIV‐1‐Infected Patients Receiving Antiretroviral Therapy

P. Portegies, S. Danner, S. Jurriaans, 2000, Journal of acquired immune deficiency syndromes.

Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy.

P. Portegies, J. Goudsmit, S. Danner, 2000 .

Primary central nervous system lymphoma.

E. Richard, P. Portegies, M. Brouwer, 2007, Handbook of clinical neurology.

Clinical Neurology in AIDS

P. Portegies, 1993 .

EFNS guideline on the management of community‐acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults

A. Chaudhuri, P. Portegies, M. Bojar, 2008, European journal of neurology.

Epstein-Barr virus and the nervous system.

P. Portegies, N. Corssmit, 2000, Current opinion in neurology.

Severe neurological complications in association with Epstein-Barr virus infection.

P. Portegies, M. L. Leverstein-van Hall, P. Bakker, 1997, Journal of neurovirology.

HIV-1 infection and cognitive impairment in the cART era: a review.

P. Reiss, J. Schouten, P. Portegies, 2011, AIDS.

Selection of An M184V Mutation in the Cerebrospinal Fluid of a Treatment-Naive HIV-Infected Individual Starting Darunavir-Based Therapy

P. Portegies, M. van der Valk, M. Cornelissen, 2011, Antiviral therapy.

Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.

P. Portegies, H. Speelman, J. Goudsmit, 1989, BMJ.

Human immunodeficiency virus type 1 antigen in cerebrospinal fluid. Correlation with clinical neurologic status.

L. Epstein, P. Portegies, J. Goudsmit, 1989, Archives of neurology.

Introduction: HIV/AIDS and Aging.

D. Stoff, P. Portegies, A. Monjan, 2004, AIDS.

AIDS dementia complex and didanosine

P. Reiss, P. Portegies, J. Goudsmit, 1994, The Lancet.

Reduced Forced Vital Capacity Among Human Immunodeficiency Virus-Infected Middle-Aged Individuals

T. van der Poll, P. Lips, F. Verbraak, 2018, The Journal of infectious diseases.

Recurrent Varicella-Zoster Virus Myelitis in an Immunocompetent Patient

C. Visser, P. Portegies, H. Jacobus Gilhuis, 2004, European Neurology.

Subjecting Acute Ischemic Stroke Patients to Continuous Tube Feeding and an Intensive Computerized Protocol Establishes Tight Glycemic Control

L. Kappelle, J. DeVries, P. Portegies, 2010, Neurocritical care.

Predominance of polymorphonuclear leukocytes in cerebrospinal fluid of AIDS patients with cytomegalovirus polyradiculomyelitis.

D. Troost, P. Portegies, J. A. Tutuarima, 1990, Journal of acquired immune deficiency syndromes.

Single Nucleotide Polymorphism in Gene Encoding Transcription Factor Prep1 Is Associated with HIV-1-Associated Dementia

E. Bunnik, H. Schuitemaker, A. B. van 't Wout, 2012, PloS one.

Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex.

H. Schuitemaker, A. B. van 't Wout, P. Portegies, 1999, The Journal of infectious diseases.

HIV-1, the brain, and combination therapy

P. Portegies, 1995, The Lancet.

Nitric oxide synthase expression and apoptotic cell death in brains of AIDS and AIDS dementia patients.

D. Troost, P. Portegies, P. Lucassen, 1999, AIDS.

[Progressive multifocal leukoencephalopathy in AIDS].

J. Valk, P. Algra, P. Portegies, 1992, Nederlands tijdschrift voor geneeskunde.

Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy

P. Reiss, B. Schmand, T. Su, 2016, AIDS.

No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) Project

D. Sharp, R. Leech, A. Winston, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy

D. Sharp, P. Reiss, J. Cole, 2016, AIDS.

High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid

C. Franceschi, B. Berkhout, R. Leech, 2017, Open forum infectious diseases.

Presentation and course of AIDS dementia complex

P. Algra, P. Portegies, J. Goudsmit, 1993 .

Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy

D. Sharp, P. Reiss, E. Richard, 2017, AIDS.

WHITE MATTER HYPERINTENSITIES IN RELATION TO COGNITION IN HIV-INFECTED MEN WITH SuSTAINED SuPPRESSED VIRAL LOAD ON CART

D. Sharp, J. Cole, E. Richard, 2017 .

Review of Antiretroviral Therapy in the Prevention of HIV-Related AIDS Dementia Complex (ADC)

P. Portegies, 2012, Drugs.

AIDS dementia complex: a review.

P. Portegies, 1994, Journal of acquired immune deficiency syndromes.

Reduced Prevalence of the CCR 5 D 32 Heterozygous Genotype in Human Immunodeficiency Virus – Infected Individuals with AIDS Dementia Complex

H. Schuitemaker, P. Portegies, J. Lange, 1999 .

CONCISE COMMUNICATIONS Reduced Prevalence of the CCR5 D32 Heterozygous Genotype in Human Immunodeficiency Virus-Infected Individuals with AIDS Dementia Complex

H. Schuitemaker, P. Portegies, J. Lange, 1999 .

Neuropathogenesis of HIV-1 Infection Dementia Complex : Implications for the Increased Peroxynitrite Activity in AIDS

Gray, P. Portegies, J. Verhoef, 1999 .

Myelography in patients with acquired immuno deficiency syndrome

P. Portegies, F. Peeters, P. A. Koster, 1989, Neuroradiology.

HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier.

J. Beijnen, C. Boucher, P. Portegies, 1997, Antiviral Therapy.

Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection.

P. Portegies, S. Jurriaans, J. Prins, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Aids Dementia Complex

P. Portegies, R. Enting, 2000 .

Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex.

C. Kuiken, P. Portegies, J. Goudsmit, 1995, The Journal of general virology.

Pyrimethamine alone as maintenance therapy for central nervous system toxoplasmosis in 38 patients with AIDS.

D. Troost, P. Reiss, P. Portegies, 1992, Journal of acquired immune deficiency syndromes.

A gait disorder with an unexpected twist

P. Portegies, M. V. Kasteren, BR Bloem, 2003, The Lancet.

Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS

P. Reiss, P. Portegies, J. Gans, 1992, The Lancet.

Low frequency of neurosyphilis in HIV-infected individuals

R. Esselink, P. Portegies, R. Enting, 1993, The Lancet.

Subjecting Acute Ischemic Stroke Patients to Continuous Tube Feeding and an Intensive Computerized Protocol Establishes Tight Glycemic Control

L. Kappelle, G. Biessels, J. DeVries, 2010, Neurocritical care.

Therapy for cytomegalovirus polyradieulomyelitis in patients with AIDS: treatment with ganciclovir

D. Troost, P. Portegies, S. Danner, 1990, AIDS.

Mental changes in patients with AIDS

P. Portegies, J. Stam, J. Gans, 1990, Clinical Neurology and Neurosurgery.